FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Sun Pharmaceutical Industries buPROPion Hydrochloride Extended-release Recall

buPROPion Hydrochloride Extended-release Tablets, USP (SR), 200 mg, 60 count bottles, R…

Sun Pharmaceutical Industries, Inc. · Cranbury, NJ

Risk level
Class III
Reported by FDA
Feb 1, 2017
Recall ID
D-0446-2017
Check your lot numberHow we source this data

Summary

Sun Pharmaceutical Industries recalled buPROPion Hydrochloride Extended-release starting Dec 20, 2016. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0446-2017 on Feb 1, 2017. Reason: Failed Dissolution Specifications; 18 month stability time point. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications; 18 month stability time point

Product description

buPROPion Hydrochloride Extended-release Tablets, USP (SR), 200 mg, 60 count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India NDC 47335-0738-86

Lot numbers, UPCs & expiration codes

JKP0905A 04/17

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0446-2017
Classification
Class III
Status
Terminated
Recall initiated
Dec 20, 2016
FDA report date
Feb 1, 2017
Quantity
11,618 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Sun Pharmaceutical Industries, Inc.

Original FDA data

Every field from FDA enforcement report D-0446-2017, exactly as published.

Show all FDA fields
City
Cranbury
State
NJ
Status
Terminated
Country
United States
Event ID
76282
Address
270 Prospect Plains Rd
Code information
JKP0905A 04/17
Postal code
08512-3605
Report date
Feb 1, 2017
Product type
Drugs
Recall number
D-0446-2017
Classification
Class III
Recalling firm
Sun Pharmaceutical Industries, Inc.
Product quantity
11,618 bottles
Termination date
Jul 11, 2018
Reason for recall
Failed Dissolution Specifications; 18 month stability time point
Voluntary / mandated
Voluntary: Firm initiated
Product description
buPROPion Hydrochloride Extended-release Tablets, USP (SR), 200 mg, 60 count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India NDC 47335-0738-86
Distribution pattern
Nationwide
Recall initiation date
Dec 20, 2016
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Jan 25, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0446-2017, published Feb 1, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls